Pharmaceutical pricing dynamics in an internal reference pricing system: evidence from changing drugs' reimbursements [0.03%]
内部参考定价体系下的药品价格动态机制——来自药品报销制度改革的证据
Eduardo Costa,Carolina Santos
Eduardo Costa
Reference pricing systems for prescription drugs are usually implemented with the aim of curbing public expenditure with pharmaceuticals, induce drug substitution from branded to generic drugs, and enhance competition. In these systems, pat...
Equity in healthcare utilization in Canada's publicly funded health system: 2000-2014 [0.03%]
加拿大公共资助卫生体系中2000至2014年的卫生保健利用公平性
Laura Hirello,Mohammad Habibullah Pulok,Mohammad Hajizadeh
Laura Hirello
Equity in healthcare utilization is a globally accepted measurement of health system performance. In Canada, equity is included as a policy goal in the Federal health legislation that governs healthcare systems. This study used ten cycles o...
Steven Stillman,Mirco Tonin
Steven Stillman
The response to the COVID-19 epidemic requires people to undertake actions such as mask-wearing or vaccination that also confer benefits to the whole community, and therefore, are akin to public good contributions. This is the case also for...
Determinants of willingness to pay for health services: a systematic review of contingent valuation studies [0.03%]
影响健康服务支付意愿的因素：一种关于悬赏评价研究的系统性综述
Caroline Steigenberger,Magdalena Flatscher-Thoeni,Uwe Siebert et al.
Caroline Steigenberger et al.
Introduction: Stated preference studies are a valuable tool to elicit respondents' willingness to pay (WTP) for goods or services, especially in situations where no market valuation exists. Contingent valuation (CV) is a ...
Population preferences for non-pharmaceutical interventions to control the SARS-CoV-2 pandemic: trade-offs among public health, individual rights, and economics [0.03%]
控制SARS-CoV-2大流行的非药物干预措施的人群偏好：公共卫生、个人权利和经济之间的权衡关系
Axel C Mühlbacher,Andrew Sadler,Yvonne Jordan
Axel C Mühlbacher
Problem: Policymakers must decide on interventions to control the pandemic. These decisions are driven by weighing the risks and benefits of various non-pharmaceutical intervention alternatives. Due to the nature of the p...
Reassessing the impact of health expenditure on income growth in the face of the global sanitary crisis: the case of developing countries [0.03%]
全球卫生危机下的发展中国家医疗卫生支出对经济增长的影响再评估研究
Brahim Gaies
Brahim Gaies
In response to the COVID-19 pandemic, developing countries are increasing health spending to save lives. Such a response raises questions about the economic impact of this expenditure in terms of income growth that determines the developmen...
Should administrative costs in health insurance be included in the risk-equalization? An analysis of five countries [0.03%]
健康保险的行政开销应纳入风险调节范围吗？五国分析结果
Rudy Douven,Lukas Kauer,Sylvia Demme et al.
Rudy Douven et al.
Most countries that apply risk-equalization in their health insurance market(s) perform risk-equalization on medical claims but do not include other components of the insurance premium, such as administrative costs. Using fixed effects pane...
Does voluntary health insurance improve health and longevity? Evidence from European OECD countries [0.03%]
自愿性健康保险改善健康和寿命吗？来自欧洲OECD国家的证据
Simona Laura Dragos,Codruta Mare,Cristian Mihai Dragos et al.
Simona Laura Dragos et al.
The financing structure of the healthcare system and, particularly, the voluntary health insurance (VHI) constituent, has been a vital pillar in improving the overall quality of life. Consequently, this study aims to shed light on the effec...
Psychometric performance of proxy-reported EQ-5D youth version 5-level (EQ-5D-Y-5L) in comparison with three-level (EQ-5D-Y-3L) in children and adolescents with scoliosis [0.03%]
与三水平版本相比，青少年 idiopathic scoliosis 患者中代理报告的 EQ-5D 少年人群版五级系统（EQ-5D-Y-5L）的心理测量性能评估
Jiaer Lin,Carlos King Ho Wong,Jason Pui Yin Cheung et al.
Jiaer Lin et al.
Objectives: To assess the psychometric performance of proxy-reported EQ-5D-Y-5L (Y-5L) in comparisons with EQ-5D-Y-3L (Y-3L) administered by caregivers of patients with juvenile (JIS) or adolescent idiopathic scoliosis (A...
Generating EQ-5D-5L health utility scores from BASDAI and BASFI: a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data [0.03%]
基于纵向英国登记数据的轴向脊柱关节炎患者的BASDAI和BASFI生成EQ-5D-5L健康效用评分：映射研究
Aileen R Neilson,Gareth T Jones,Gary J Macfarlane et al.
Aileen R Neilson et al.
Background: Preference-based health-state utility values (HSUVs), such as the EuroQol five-dimensional questionnaire (EQ-5D-5L), are needed to calculate quality-adjusted life-years (QALYs) for cost-effectiveness analyses....